AMH and ovarian hyperstimulation syndrome: Recently, an individualized dosing algorithm of follitropin delta applying serum AMH and body weight to determine the follitropin delta dose has been shown to decrease the incidence of moderate or severe ovarian hyperstimulation syndrome (OHSS) as well as incidence of preventive interventions for early OHSS compared with conventional treatment in women without compromising the live birth rates [1].